Character Biosciences

Character Biosciences, founded as Character Therapeutics, is a biopharmaceutical research and development company focused on precision medicine for ophthalmology. The company's core mission is to leverage human genetics, genomics, longitudinal clinical and imaging data, and machine learning to understand the molecular drivers of disease progression. By doing so, Character Biosciences aims to develop innovative targeted therapies, particularly for progressive polygenic diseases like macular degeneration, providing treatment options for patients who currently have none.

Character Biosciences collaborates with clinical genomic researchers to ensure high standards of privacy, data security, ethics, and scientific rigor. Notable affiliated individuals and investors include experts in genomics and machine learning, although specific names are not provided. The company's key achievements include pioneering approaches in identifying disease patterns and developing targeted medicines that address unmet medical needs. Overall, Character Biosciences has made a significant impact by advancing the field of precision medicine and offering hope to patients with previously untreatable conditions.